$33.85
-1.49-4.22%
At close: Jan 14, 4:00 PM EST
$34.32
-1.02-2.89%
Pre-Market: 6:28 AM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Genmab Stock Guidance | NASDAQ:GMAB | Benzinga
Genmab issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/06/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.50B | $3.70B | $15.70B | Get Alert |
| 08/07/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.50B | $3.70B | $15.41B | Get Alert |
| 05/08/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.34B | $3.66B | $3.71B | Get Alert |
| 02/12/2025 | GMAB | Genmab | FY | 2025 | — | — | — | $3.34B | $3.66B | $3.51B | Get Alert |
| 11/06/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $3.11B | $3.20B | $3.08B | Get Alert |
| 08/08/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.96B | $3.13B | $2.89B | Get Alert |
| 05/02/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.72B | $2.98B | $2.84B | Get Alert |
| 02/14/2024 | GMAB | Genmab | FY | 2024 | — | — | — | $2.70B | $2.96B | $2.76B | Get Alert |
| 11/07/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $2.32B | $2.41B | $2.30B | Get Alert |
| 07/28/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $2.27B | $2.41B | $2.38B | Get Alert |
| 05/10/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $1.94B | $2.13B | $2.31B | Get Alert |
| 02/22/2023 | GMAB | Genmab | FY | 2023 | — | — | — | $1.94B | $2.13B | $2.44B | Get Alert |
| 11/09/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.83B | $1.97B | $1.72B | Get Alert |
| 11/03/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.88B | $2.01B | $1.68B | Get Alert |
| 08/10/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.72B | $1.86B | — | Get Alert |
| 08/08/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.72B | $1.86B | — | Get Alert |
| 05/11/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.66B | $1.81B | — | Get Alert |
| 02/16/2022 | GMAB | Genmab | FY | 2022 | — | — | — | $1.66B | $1.85B | $1.68B | Get Alert |
FAQ
Q
What is the most recent guidance for Genmab (GMAB)?
A
There have been no specific sales or earnings guidance reported for Genmab in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved